Phase I trial of first-line bortezomib/thalidomide plus chemotherapy for induction and stem cell mobilization in patients with multiple myeloma

Ashraf Badros, Olga Goloubeva, Robert Fenton, Aaron P. Rapoport, Gorgun Akpek, Carolynn Harris, Kathleen Ruehle, Sandra Westphal, Barry Meisenberg

Research output: Contribution to journalArticlepeer-review

34 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I trial of first-line bortezomib/thalidomide plus chemotherapy for induction and stem cell mobilization in patients with multiple myeloma'. Together they form a unique fingerprint.

Medicine & Life Sciences